[{"AccountsPayableCurrent_0_Q3_USD":16222000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":80725000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":13586000.0,"OperatingLeaseLiability_0_Q3_USD":119899000.0,"OperatingLeaseExpense_3_Q3_USD":12200000.0,"OperatingLeaseExpense_1_Q3_USD":5400000.0,"OperatingIncomeLoss_3_Q3_USD":-164609000.0,"OperatingIncomeLoss_1_Q3_USD":-69201000.0,"OperatingExpenses_3_Q3_USD":179437000.0,"OperatingExpenses_1_Q3_USD":74638000.0,"NonoperatingIncomeExpense_3_Q3_USD":708000.0,"NonoperatingIncomeExpense_1_Q3_USD":231000.0,"NetIncomeLoss_1_Q3_USD":-76086000.0,"NetIncomeLoss_3_Q3_USD":-184744000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-97785000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-195112000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":300474000.0,"LongTermDebtNoncurrent_0_Q3_USD":30203000.0,"LongTermDebtFairValue_0_Q3_USD":47100000.0,"LongTermDebtCurrent_0_Q3_USD":16875000.0,"LiabilitiesCurrent_0_Q3_USD":80868000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":827539000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":4969000.0,"OtherAssetsNoncurrent_0_Q3_USD":6682000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-43000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-214000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":3988000.0,"StockholdersEquity_0_Q3_USD":249020000.0,"ShareBasedCompensation_3_Q3_USD":20121000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":83208000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":14828000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":5437000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1177050000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":116440000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":48436000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":2635000.0,"Liabilities_0_Q3_USD":578519000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":53896000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":3300000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":326156000.0,"ProceedsFromIssuanceOfPrivatePlacement_3_Q3_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":16661000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":31118000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":493450000.0,"OtherLiabilitiesCurrent_0_Q3_USD":2413000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-43000.0,"ProfitLoss_3_Q3_USD":-184744000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":80329.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":115081000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":17107000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-184958000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-76129000.0,"CommonStockValue_0_Q3_USD":84000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommitmentsAndContingencies_0_Q3_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":7577000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":90562000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":90562000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":10974000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q3_USD":191295000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":387074000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":666607000.0,"AssetsCurrent_0_Q3_USD":494941000.0,"Assets_0_Q3_USD":827539000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":27787000.0,"AmortizationOfFinancingCosts_1_Q3_USD":30000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":7767000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1426051000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-65000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":31772000.0,"AccountsReceivableNetCurrent_0_Q3_USD":644000.0,"ConvertibleDebtFairValueDisclosures_0_Q3_USD":458600000.0,"DebtSecuritiesAvailableForSaleGainLoss_3_Q3_USD":0.0,"DeferredRevenueNoncurrent_0_Q3_USD":87000000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":1542000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":17668000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":18249000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":163434000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":234980000.0,"InvestmentIncomeInterest_3_Q3_USD":700000.0,"InvestmentIncomeInterest_1_Q3_USD":200000.0,"InterestExpense_3_Q3_USD":12222000.0,"InterestExpense_1_Q3_USD":4161000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":11244000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":5475000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":15887000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":13821000.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":-2802000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":62997000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":26202000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_3_Q3_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":11749000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.48,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.95,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-3776000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":74460.0,"Ticker":"CYTK","CIK":"1061983","name":"CYTOKINETICS INC","OfficialName":"Cytokinetics Incorporated Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3243164482.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]